Curaleaf (OTCMKTS:CURLF) Trading Up 7.8% – Still a Buy?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) rose 7.8% on Tuesday . The stock traded as high as $11.31 and last traded at $11.26. 105,528 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 293,632 shares. The stock had previously closed at $10.45.

Analysts Set New Price Targets

CURLF has been the topic of a number of recent analyst reports. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Performance

The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. The company’s 50-day moving average is $9.53 and its two-hundred day moving average is $8.28. The firm has a market cap of $2.60 billion, a P/E ratio of -85.76 and a beta of 1.57.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.25. The business had revenue of $340.10 million during the quarter, compared to the consensus estimate of $332.00 million. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%. As a group, equities analysts predict that Curaleaf Holdings, Inc. will post 0.01 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products in the United States and select international markets. Its operations include cannabis cultivation and processing facilities, retail dispensaries and wholesale distribution, serving both medical cannabis patients and adult-use consumers where permitted by law.

The company offers a broad portfolio of products, including cannabis flower, pre-rolls, vape products, concentrates, edibles, tinctures and other wellness-oriented products.